 | • レポートコード：QYR2104Z5101 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、唾液腺感染症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、診療所、家庭用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・唾液腺感染症の市場動向 ・企業の競争状況、市場シェア ・唾液腺感染症の種類別市場規模（診断、治療） ・唾液腺感染症の用途別市場規模（病院、診療所、家庭用、その他） ・唾液腺感染症の北米市場規模2016-2027（アメリカ、カナダ） ・唾液腺感染症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・唾液腺感染症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・唾液腺感染症の中南米市場規模2016-2027（メキシコ、ブラジル） ・唾液腺感染症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc. (US)、Allergan (Republic of Ireland)、AstraZeneca (UK)、FUJIFILM Holdings Corporation (Japan)、General Electric Company (US)、GlaxoSmithKline plc. (UK)、Johnson & Johnson Services(US)、Merck & Co.(US)、Pfizer Inc.(US)、Siemens Healthcare GmbH (Germany)） ・結論 |
Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland.
Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.
Market Analysis and Insights: Global Salivary Gland Infection Market
The global Salivary Gland Infection market size is projected to reach US$ 3409.7 million by 2026, from US$ 2618.6 million in 2019, at a CAGR of 3.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Salivary Gland Infection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Salivary Gland Infection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Salivary Gland Infection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Salivary Gland Infection market.
Global Salivary Gland Infection Scope and Market Size
Salivary Gland Infection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Salivary Gland Infection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospital
Clinic
Household
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie Inc. (US)
Allergan (Republic of Ireland)
AstraZeneca (UK)
FUJIFILM Holdings Corporation (Japan)
General Electric Company (US)
GlaxoSmithKline plc. (UK)
Johnson & Johnson Services(US)
Merck & Co.(US)
Pfizer Inc.(US)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Salivary Gland Infection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Salivary Gland Infection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Salivary Gland Infection Market Perspective (2016-2027)
2.2 Salivary Gland Infection Growth Trends by Regions
2.2.1 Salivary Gland Infection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Salivary Gland Infection Historic Market Share by Regions (2016-2021)
2.2.3 Salivary Gland Infection Forecasted Market Size by Regions (2022-2027)
2.3 Salivary Gland Infection Industry Dynamic
2.3.1 Salivary Gland Infection Market Trends
2.3.2 Salivary Gland Infection Market Drivers
2.3.3 Salivary Gland Infection Market Challenges
2.3.4 Salivary Gland Infection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Salivary Gland Infection Players by Revenue
3.1.1 Global Top Salivary Gland Infection Players by Revenue (2016-2021)
3.1.2 Global Salivary Gland Infection Revenue Market Share by Players (2016-2021)
3.2 Global Salivary Gland Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Salivary Gland Infection Revenue
3.4 Global Salivary Gland Infection Market Concentration Ratio
3.4.1 Global Salivary Gland Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Salivary Gland Infection Revenue in 2020
3.5 Salivary Gland Infection Key Players Head office and Area Served
3.6 Key Players Salivary Gland Infection Product Solution and Service
3.7 Date of Enter into Salivary Gland Infection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Salivary Gland Infection Breakdown Data by Type
4.1 Global Salivary Gland Infection Historic Market Size by Type (2016-2021)
4.2 Global Salivary Gland Infection Forecasted Market Size by Type (2022-2027)
5 Salivary Gland Infection Breakdown Data by Application
5.1 Global Salivary Gland Infection Historic Market Size by Application (2016-2021)
5.2 Global Salivary Gland Infection Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Salivary Gland Infection Market Size (2016-2027)
6.2 North America Salivary Gland Infection Market Size by Type
6.2.1 North America Salivary Gland Infection Market Size by Type (2016-2021)
6.2.2 North America Salivary Gland Infection Market Size by Type (2022-2027)
6.2.3 North America Salivary Gland Infection Market Size by Type (2016-2027)
6.3 North America Salivary Gland Infection Market Size by Application
6.3.1 North America Salivary Gland Infection Market Size by Application (2016-2021)
6.3.2 North America Salivary Gland Infection Market Size by Application (2022-2027)
6.3.3 North America Salivary Gland Infection Market Size by Application (2016-2027)
6.4 North America Salivary Gland Infection Market Size by Country
6.4.1 North America Salivary Gland Infection Market Size by Country (2016-2021)
6.4.2 North America Salivary Gland Infection Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Salivary Gland Infection Market Size (2016-2027)
7.2 Europe Salivary Gland Infection Market Size by Type
7.2.1 Europe Salivary Gland Infection Market Size by Type (2016-2021)
7.2.2 Europe Salivary Gland Infection Market Size by Type (2022-2027)
7.2.3 Europe Salivary Gland Infection Market Size by Type (2016-2027)
7.3 Europe Salivary Gland Infection Market Size by Application
7.3.1 Europe Salivary Gland Infection Market Size by Application (2016-2021)
7.3.2 Europe Salivary Gland Infection Market Size by Application (2022-2027)
7.3.3 Europe Salivary Gland Infection Market Size by Application (2016-2027)
7.4 Europe Salivary Gland Infection Market Size by Country
7.4.1 Europe Salivary Gland Infection Market Size by Country (2016-2021)
7.4.2 Europe Salivary Gland Infection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Salivary Gland Infection Market Size (2016-2027)
8.2 Asia-Pacific Salivary Gland Infection Market Size by Type
8.2.1 Asia-Pacific Salivary Gland Infection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Salivary Gland Infection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Salivary Gland Infection Market Size by Type (2016-2027)
8.3 Asia-Pacific Salivary Gland Infection Market Size by Application
8.3.1 Asia-Pacific Salivary Gland Infection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Salivary Gland Infection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Salivary Gland Infection Market Size by Application (2016-2027)
8.4 Asia-Pacific Salivary Gland Infection Market Size by Region
8.4.1 Asia-Pacific Salivary Gland Infection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Salivary Gland Infection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Salivary Gland Infection Market Size (2016-2027)
9.2 Latin America Salivary Gland Infection Market Size by Type
9.2.1 Latin America Salivary Gland Infection Market Size by Type (2016-2021)
9.2.2 Latin America Salivary Gland Infection Market Size by Type (2022-2027)
9.2.3 Latin America Salivary Gland Infection Market Size by Type (2016-2027)
9.3 Latin America Salivary Gland Infection Market Size by Application
9.3.1 Latin America Salivary Gland Infection Market Size by Application (2016-2021)
9.3.2 Latin America Salivary Gland Infection Market Size by Application (2022-2027)
9.3.3 Latin America Salivary Gland Infection Market Size by Application (2016-2027)
9.4 Latin America Salivary Gland Infection Market Size by Country
9.4.1 Latin America Salivary Gland Infection Market Size by Country (2016-2021)
9.4.2 Latin America Salivary Gland Infection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Salivary Gland Infection Market Size (2016-2027)
10.2 Middle East & Africa Salivary Gland Infection Market Size by Type
10.2.1 Middle East & Africa Salivary Gland Infection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Salivary Gland Infection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Salivary Gland Infection Market Size by Type (2016-2027)
10.3 Middle East & Africa Salivary Gland Infection Market Size by Application
10.3.1 Middle East & Africa Salivary Gland Infection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Salivary Gland Infection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Salivary Gland Infection Market Size by Application (2016-2027)
10.4 Middle East & Africa Salivary Gland Infection Market Size by Country
10.4.1 Middle East & Africa Salivary Gland Infection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Salivary Gland Infection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie Inc. (US)
11.1.1 AbbVie Inc. (US) Company Details
11.1.2 AbbVie Inc. (US) Business Overview
11.1.3 AbbVie Inc. (US) Salivary Gland Infection Introduction
11.1.4 AbbVie Inc. (US) Revenue in Salivary Gland Infection Business (2016-2021)
11.1.5 AbbVie Inc. (US) Recent Development
11.2 Allergan (Republic of Ireland)
11.2.1 Allergan (Republic of Ireland) Company Details
11.2.2 Allergan (Republic of Ireland) Business Overview
11.2.3 Allergan (Republic of Ireland) Salivary Gland Infection Introduction
11.2.4 Allergan (Republic of Ireland) Revenue in Salivary Gland Infection Business (2016-2021)
11.2.5 Allergan (Republic of Ireland) Recent Development
11.3 AstraZeneca (UK)
11.3.1 AstraZeneca (UK) Company Details
11.3.2 AstraZeneca (UK) Business Overview
11.3.3 AstraZeneca (UK) Salivary Gland Infection Introduction
11.3.4 AstraZeneca (UK) Revenue in Salivary Gland Infection Business (2016-2021)
11.3.5 AstraZeneca (UK) Recent Development
11.4 FUJIFILM Holdings Corporation (Japan)
11.4.1 FUJIFILM Holdings Corporation (Japan) Company Details
11.4.2 FUJIFILM Holdings Corporation (Japan) Business Overview
11.4.3 FUJIFILM Holdings Corporation (Japan) Salivary Gland Infection Introduction
11.4.4 FUJIFILM Holdings Corporation (Japan) Revenue in Salivary Gland Infection Business (2016-2021)
11.4.5 FUJIFILM Holdings Corporation (Japan) Recent Development
11.5 General Electric Company (US)
11.5.1 General Electric Company (US) Company Details
11.5.2 General Electric Company (US) Business Overview
11.5.3 General Electric Company (US) Salivary Gland Infection Introduction
11.5.4 General Electric Company (US) Revenue in Salivary Gland Infection Business (2016-2021)
11.5.5 General Electric Company (US) Recent Development
11.6 GlaxoSmithKline plc. (UK)
11.6.1 GlaxoSmithKline plc. (UK) Company Details
11.6.2 GlaxoSmithKline plc. (UK) Business Overview
11.6.3 GlaxoSmithKline plc. (UK) Salivary Gland Infection Introduction
11.6.4 GlaxoSmithKline plc. (UK) Revenue in Salivary Gland Infection Business (2016-2021)
11.6.5 GlaxoSmithKline plc. (UK) Recent Development
11.7 Johnson & Johnson Services(US)
11.7.1 Johnson & Johnson Services(US) Company Details
11.7.2 Johnson & Johnson Services(US) Business Overview
11.7.3 Johnson & Johnson Services(US) Salivary Gland Infection Introduction
11.7.4 Johnson & Johnson Services(US) Revenue in Salivary Gland Infection Business (2016-2021)
11.7.5 Johnson & Johnson Services(US) Recent Development
11.8 Merck & Co.(US)
11.8.1 Merck & Co.(US) Company Details
11.8.2 Merck & Co.(US) Business Overview
11.8.3 Merck & Co.(US) Salivary Gland Infection Introduction
11.8.4 Merck & Co.(US) Revenue in Salivary Gland Infection Business (2016-2021)
11.8.5 Merck & Co.(US) Recent Development
11.9 Pfizer Inc.(US)
11.9.1 Pfizer Inc.(US) Company Details
11.9.2 Pfizer Inc.(US) Business Overview
11.9.3 Pfizer Inc.(US) Salivary Gland Infection Introduction
11.9.4 Pfizer Inc.(US) Revenue in Salivary Gland Infection Business (2016-2021)
11.9.5 Pfizer Inc.(US) Recent Development
11.10 Siemens Healthcare GmbH (Germany)
11.10.1 Siemens Healthcare GmbH (Germany) Company Details
11.10.2 Siemens Healthcare GmbH (Germany) Business Overview
11.10.3 Siemens Healthcare GmbH (Germany) Salivary Gland Infection Introduction
11.10.4 Siemens Healthcare GmbH (Germany) Revenue in Salivary Gland Infection Business (2016-2021)
11.10.5 Siemens Healthcare GmbH (Germany) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Salivary Gland Infection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Salivary Gland Infection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Salivary Gland Infection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Salivary Gland Infection Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Salivary Gland Infection Market Share by Regions (2016-2021)
Table 8. Global Salivary Gland Infection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Salivary Gland Infection Market Share by Regions (2022-2027)
Table 10. Salivary Gland Infection Market Trends
Table 11. Salivary Gland Infection Market Drivers
Table 12. Salivary Gland Infection Market Challenges
Table 13. Salivary Gland Infection Market Restraints
Table 14. Global Salivary Gland Infection Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Salivary Gland Infection Market Share by Players (2016-2021)
Table 16. Global Top Salivary Gland Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Salivary Gland Infection as of 2020)
Table 17. Ranking of Global Top Salivary Gland Infection Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Salivary Gland Infection Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Salivary Gland Infection Product Solution and Service
Table 21. Date of Enter into Salivary Gland Infection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Salivary Gland Infection Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Salivary Gland Infection Revenue Market Share by Type (2016-2021)
Table 25. Global Salivary Gland Infection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Salivary Gland Infection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Salivary Gland Infection Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Salivary Gland Infection Revenue Market Share by Application (2016-2021)
Table 29. Global Salivary Gland Infection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Salivary Gland Infection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Salivary Gland Infection Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Salivary Gland Infection Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Salivary Gland Infection Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Salivary Gland Infection Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Salivary Gland Infection Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Salivary Gland Infection Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Salivary Gland Infection Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Salivary Gland Infection Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Salivary Gland Infection Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Salivary Gland Infection Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Salivary Gland Infection Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Salivary Gland Infection Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Salivary Gland Infection Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Salivary Gland Infection Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Salivary Gland Infection Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Salivary Gland Infection Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Salivary Gland Infection Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Salivary Gland Infection Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Salivary Gland Infection Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Salivary Gland Infection Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Salivary Gland Infection Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Salivary Gland Infection Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Salivary Gland Infection Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Salivary Gland Infection Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Salivary Gland Infection Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Salivary Gland Infection Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Salivary Gland Infection Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Salivary Gland Infection Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Salivary Gland Infection Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Salivary Gland Infection Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Inc. (US) Company Details
Table 62. AbbVie Inc. (US) Business Overview
Table 63. AbbVie Inc. (US) Salivary Gland Infection Product
Table 64. AbbVie Inc. (US) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 65. AbbVie Inc. (US) Recent Development
Table 66. Allergan (Republic of Ireland) Company Details
Table 67. Allergan (Republic of Ireland) Business Overview
Table 68. Allergan (Republic of Ireland) Salivary Gland Infection Product
Table 69. Allergan (Republic of Ireland) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 70. Allergan (Republic of Ireland) Recent Development
Table 71. AstraZeneca (UK) Company Details
Table 72. AstraZeneca (UK) Business Overview
Table 73. AstraZeneca (UK) Salivary Gland Infection Product
Table 74. AstraZeneca (UK) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca (UK) Recent Development
Table 76. FUJIFILM Holdings Corporation (Japan) Company Details
Table 77. FUJIFILM Holdings Corporation (Japan) Business Overview
Table 78. FUJIFILM Holdings Corporation (Japan) Salivary Gland Infection Product
Table 79. FUJIFILM Holdings Corporation (Japan) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 80. FUJIFILM Holdings Corporation (Japan) Recent Development
Table 81. General Electric Company (US) Company Details
Table 82. General Electric Company (US) Business Overview
Table 83. General Electric Company (US) Salivary Gland Infection Product
Table 84. General Electric Company (US) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 85. General Electric Company (US) Recent Development
Table 86. GlaxoSmithKline plc. (UK) Company Details
Table 87. GlaxoSmithKline plc. (UK) Business Overview
Table 88. GlaxoSmithKline plc. (UK) Salivary Gland Infection Product
Table 89. GlaxoSmithKline plc. (UK) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline plc. (UK) Recent Development
Table 91. Johnson & Johnson Services(US) Company Details
Table 92. Johnson & Johnson Services(US) Business Overview
Table 93. Johnson & Johnson Services(US) Salivary Gland Infection Product
Table 94. Johnson & Johnson Services(US) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 95. Johnson & Johnson Services(US) Recent Development
Table 96. Merck & Co.(US) Company Details
Table 97. Merck & Co.(US) Business Overview
Table 98. Merck & Co.(US) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 99. Merck & Co.(US) Recent Development
Table 100. Pfizer Inc.(US) Company Details
Table 101. Pfizer Inc.(US) Business Overview
Table 102. Pfizer Inc.(US) Salivary Gland Infection Product
Table 103. Pfizer Inc.(US) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 104. Pfizer Inc.(US) Recent Development
Table 105. Siemens Healthcare GmbH (Germany) Company Details
Table 106. Siemens Healthcare GmbH (Germany) Business Overview
Table 107. Siemens Healthcare GmbH (Germany) Salivary Gland Infection Product
Table 108. Siemens Healthcare GmbH (Germany) Revenue in Salivary Gland Infection Business (2016-2021) & (US$ Million)
Table 109. Siemens Healthcare GmbH (Germany) Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Salivary Gland Infection Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Salivary Gland Infection Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Household Case Studies
Figure 8. Other Case Studies
Figure 9. Salivary Gland Infection Report Years Considered
Figure 10. Global Salivary Gland Infection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Salivary Gland Infection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Salivary Gland Infection Market Share by Regions: 2020 VS 2027
Figure 13. Global Salivary Gland Infection Market Share by Regions (2022-2027)
Figure 14. Global Salivary Gland Infection Market Share by Players in 2020
Figure 15. Global Top Salivary Gland Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Salivary Gland Infection as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Salivary Gland Infection Revenue in 2020
Figure 17. Global Salivary Gland Infection Revenue Market Share by Type (2016-2021)
Figure 18. Global Salivary Gland Infection Revenue Market Share by Type (2022-2027)
Figure 19. North America Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Salivary Gland Infection Market Share by Type (2016-2027)
Figure 21. North America Salivary Gland Infection Market Share by Application (2016-2027)
Figure 22. North America Salivary Gland Infection Market Share by Country (2016-2027)
Figure 23. United States Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Salivary Gland Infection Market Share by Type (2016-2027)
Figure 27. Europe Salivary Gland Infection Market Share by Application (2016-2027)
Figure 28. Europe Salivary Gland Infection Market Share by Country (2016-2027)
Figure 29. Germany Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Salivary Gland Infection Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Salivary Gland Infection Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Salivary Gland Infection Market Share by Region (2016-2027)
Figure 39. China Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Salivary Gland Infection Market Share by Type (2016-2027)
Figure 47. Latin America Salivary Gland Infection Market Share by Application (2016-2027)
Figure 48. Latin America Salivary Gland Infection Market Share by Country (2016-2027)
Figure 49. Mexico Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Salivary Gland Infection Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Salivary Gland Infection Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Salivary Gland Infection Market Share by Country (2016-2027)
Figure 55. Turkey Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Salivary Gland Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AbbVie Inc. (US) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 59. Allergan (Republic of Ireland) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 60. AstraZeneca (UK) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 61. FUJIFILM Holdings Corporation (Japan) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 62. General Electric Company (US) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 63. GlaxoSmithKline plc. (UK) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 64. Johnson & Johnson Services(US) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 65. Merck & Co.(US) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 66. Pfizer Inc.(US) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 67. Siemens Healthcare GmbH (Germany) Revenue Growth Rate in Salivary Gland Infection Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の甲状腺障害治療市場規模・現状・予測（2021年-2027年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…- 世界の甲状腺障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thyroid Gland Disorders Treatment Market The global Thyroid Gland Disorders Treatment market size is projected to reach US$ 2032.7 million by 2026, from US$ 1782.6 million in 2019, at a CAGR of 1.9% during 2021-2026. With industry-standard accuracy in analysis an…
- 世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 世界の下気道感染症治療市場規模・現状・予測（2021年-2027年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…
- 世界の耳感染症治療市場規模・現状・予測（2021年-2027年） An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the th…